Picture of Taiko Pharmaceutical Co logo

4574 Taiko Pharmaceutical Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapMomentum Trap

Annual cashflow statement for Taiko Pharmaceutical Co, fiscal year end - December 31st, JPY millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,9863,504-8,887-4,869-3,563
Depreciation
Non-Cash Items-1623392,972-332,348
Unusual Items
Other Non-Cash Items
Changes in Working Capital-536-8463,3782,172204
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,7483,493-1,596-1,993-307
Capital Expenditures-506-220-1,600-84-114
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-241-228-222741,280
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-747-448-1,6221901,166
Financing Cash Flow Items-1-307
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-338-5813,959-9971,539
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash6452,453823-2,7242,447